Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@TonyFauci2 6
@SweepCastApp 4
@alerts_real 4
@Tickeron 3
@PennySearch 3

Recent Tweets for ALDX

DeliaSt34680601 @DeliaSt34680601
$ALDX *Hey guys, I've made $55K with them in a week, by their alerts ,._, https://t.co/PuTfVQ8aG8
January 25th 2022, 4:01am
Tickeron @Tickeron
$ALDX's Aroon indicator drops into Downtrend on January 21, 2022. View odds for this and other indicators:… https://t.co/l7M90ZBCWu
January 24th 2022, 9:01pm
SherylS15843517 @SherylS15843517
$ALDX *Hey guys, I've made $55K with them in a week, by their alerts ,,_, https://t.co/NrKr8YL4wu
January 24th 2022, 4:01am
SweepCastApp @SweepCastApp
SweepCast alerted: $ALDX with Unusual Options Activity Alerted on $7.5 PUT Expiring: 01-21-2022 worth 94K? |? The… https://t.co/4p4ExaHj5a
January 23rd 2022, 3:01pm
SharonC22112717 @SharonC22112717
$ALDX *Hey guys, I've made $55K with them in a week, by their alerts ,,_, https://t.co/eSAhmWl4Bw
January 22nd 2022, 4:01am
JuneBarton17 @JuneBarton17
$ALDX *Hey guys, I've made $55K with them in a week, by their alerts ,._, https://t.co/tUjGUoF3H1
January 19th 2022, 4:01am
TonyFauci2 @TonyFauci2
$ALDX 1st combo Allergic Conj/ Dry Eye Drop coming soon.
January 18th 2022, 8:01pm
PennySearch @PennySearch
$ALDX SVB Leerink gave ALDX a Outperform stock rating on 2021-12-21. Find top penny stocks with PennySearch befo… https://t.co/isfzyKMEti
January 18th 2022, 4:01pm
SweepCastApp @SweepCastApp
$ALDX Raytheon Technologies Option Alert: Jan 21 $80 Calls Sweep (4) near the Ask: 27 vs 2974 OI; Earnings 1/25 Bef… https://t.co/MTuyzHm8dd
January 17th 2022, 11:01pm
Tickeron @Tickeron
$ALDX in Downtrend: Stochastic indicator stays in oversold zone for 5 days. View odds for this and other indicators… https://t.co/gbraVmdEjt
January 17th 2022, 10:01am
SweepCastApp @SweepCastApp
SweepCast alerted: $ALDX with Unusual Options Activity Alerted on $7.5 PUT Expiring: 01-21-2022 worth 94K? |? Check… https://t.co/jwYMUb170Z
January 16th 2022, 7:01am
Tickeron @Tickeron
Oh wow this is big! $ALDX RSI Indicator left the oversold zone. #AldeyraTherapeutics https://t.co/hFcN2wxQbx https://t.co/bfiJJn18hO
January 15th 2022, 6:01pm
SweepCastApp @SweepCastApp
SweepCast alerted: $ALDX with Unusual Options Activity Alerted on $7.5 PUT Expiring: 01-21-2022 worth 94K? |? The… https://t.co/Cw1oMUDsRv
January 15th 2022, 3:01pm
smijotrading @smijotrading
$LGVN $ALDX and others follow smijotrading join our premium room to support our post and get some premium alerts https://t.co/5DpVgNwh4e
January 15th 2022, 1:01am
PennySearch @PennySearch
$ALDX SVB Leerink gave ALDX a Outperform stock rating on 2021-12-21. Find top penny stocks with PennySearch befo… https://t.co/RFxqyggRoV
January 15th 2022, 12:01am
shortablestocks @shortablestocks
$ALDX is short sale restricted for 2022-01-14. https://t.co/67voQULt8Z
January 14th 2022, 2:01pm
alerts_real @alerts_real
RT @HopefullyAnony2: Finally sold $ALDX for 6% profit. https://t.co/vALzFcVOYK
January 13th 2022, 5:01pm
alerts_real @alerts_real
RT @brendan_49: $ALDX news - reprox is a FAR better eye drop than xiidra, AC pivotal results now 2023, systemic PoC data this Q, & 2022 IND…
January 13th 2022, 5:01pm
alerts_real @alerts_real
RT @Quantumup1: ????? $ALDX Misses Primary Endpoint He's talking about a Moonshot?????? https://t.co/TkfwYk6PW9
January 13th 2022, 5:01pm
alerts_real @alerts_real
$ALDX Real price will come out soon; Follow price targets https://t.co/6YesXV6dRW
January 13th 2022, 5:01pm
TonyFauci2 @TonyFauci2
$ALDX - it’s building a model that doesn’t exist as a treatment in Ophthalmic Therapy in its history - I am certain… https://t.co/NlcLgezcgU
January 13th 2022, 1:01pm
PennySearch @PennySearch
$ALDX SVB Leerink gave ALDX a Outperform stock rating on 2021-12-21. Find top penny stocks with PennySearch befo… https://t.co/zUpgxzHCYJ
January 12th 2022, 9:01pm
TonyFauci2 @TonyFauci2
Not true shorty? Will gladly share my hard earned experience and subsequent enthusiasm for $ALDX
January 12th 2022, 7:01pm
TonyFauci2 @TonyFauci2
$ALDX Reproxalap - Unique- as it is proven to help both itching/burning and dryness - like a combination of HCTZ in… https://t.co/beSVZzjxlE
January 12th 2022, 7:01pm
TonyFauci2 @TonyFauci2
$ALDX stretching for the tape on Ophthalmic Biatholon - Allergic Conjunctivitis Redness and Dry Eye Schirmer’s- to… https://t.co/XvQoJEbSnf
January 12th 2022, 4:01pm
TonyFauci2 @TonyFauci2
$ALDX https://t.co/fVerphJ6xw
January 12th 2022, 4:01pm
HopefullyAnony2 @HopefullyAnony2
Finally sold $ALDX for 6% profit. https://t.co/vALzFcVOYK
January 12th 2022, 4:01pm
GetOnTrade @GetOnTrade
$ALDX Aldeyra Therapeutics Announces Top-Line Data From Phase 2 Dry Eye Chamber Clinical Trial Of Reproxalap; Says… https://t.co/GVPNrOT3Wx
January 11th 2022, 11:01pm
GetOnTrade @GetOnTrade
$ALDX Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxal… https://t.co/qGVh76McZR
January 11th 2022, 10:01pm
Quantumup1 @Quantumup1
????? $ALDX Misses Primary Endpoint He's talking about a Moonshot?????? https://t.co/1WS0oHe5mW https://t.co/TkfwYk6PW9
January 11th 2022, 9:01pm
TradeWithAlerts @TradeWithAlerts
Nice print for $ALDX Size: 184428 Price: 3.81 Amount: $702,670.68 Time: 1600 See more: https://t.co/OKnwGvRfdM Join… https://t.co/xM5L0TCM8I
January 11th 2022, 9:01pm
equity_newswire @equity_newswire
$ALDX Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxal… https://t.co/n1dAQ6ZCc5
January 11th 2022, 7:01pm
MattBiotech @MattBiotech
What say you, Biotwitter? $ALDX https://t.co/RF3fnS0MJ1
January 11th 2022, 7:01pm
TwoBobTrader @TwoBobTrader
RT @gcassidy718: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an…
January 11th 2022, 6:01pm
gcassidy718 @gcassidy718
$ALDX Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxal… https://t.co/oHk8aF5gwx
January 11th 2022, 4:01pm
Briefingcom @Briefingcom
$ALDX: Aldeyra Therapeutics announces "positive" top-line data from a Phase 2 clinical trial comparing ocular... https://t.co/hvji4IbUJR
January 11th 2022, 3:01pm
brendan_49 @brendan_49
$ALDX news - reprox is a FAR better eye drop than xiidra, AC pivotal results now 2023, systemic PoC data this Q, &… https://t.co/qHsTZwlOJl
January 11th 2022, 3:01pm
MarcJacksonLA @MarcJacksonLA
$ALDX Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxal… https://t.co/7ZgubKygbx
January 11th 2022, 2:01pm
TonyFauci2 @TonyFauci2
$ALDX positioning itself for a $NVS buyout with P2 Xiidra Spanking. https://t.co/6W085nUsVF
January 11th 2022, 2:01pm
realmaciej @realmaciej
RT @BioStocks: $ALDX Reproxalap Statistically Lower than Xiidra for the Two Endpoints of the Trial: Ocular Discomfort (p=0.002) and Ocular…
January 11th 2022, 2:01pm
Nvest_In_You @Nvest_In_You
RT @mehabecapital: $ALDX @ 3.84 (-0.26%) : Aldeyra reports positive top-line data from Phase 2 reproxalap study in dry eye disease https://…
January 11th 2022, 1:01pm
Kevin_W81 @Kevin_W81
$ALDX Cash runway into 2024 & Citigroup PT $21 Aldeyra Therapeutics Announces Positive Top-Line Data from Phase… https://t.co/sn62GelBBs
January 11th 2022, 1:01pm
mehabecapital @mehabecapital
$ALDX @ 3.84 (-0.26%) : Aldeyra reports positive top-line data from Phase 2 reproxalap study in dry eye disease https://t.co/4pX4KeTYW8
January 11th 2022, 1:01pm
MarketCurrents @MarketCurrents
$ALDX - Aldeyra reports positive top-line data from Phase 2 reproxalap study in dry eye disease https://t.co/BtqqdDTgdk
January 11th 2022, 1:01pm
Biosstocks @Biosstocks
$ALDX Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigationa… https://t.co/hSNrHLn5cG
January 11th 2022, 1:01pm
biostockinfo @biostockinfo
RT @BioStocks: $ALDX Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Dru…
January 11th 2022, 1:01pm
vtmtrading @vtmtrading
Aldeyra announces top-line data from reproxalap ophthalmic solution trial $ALDX
January 11th 2022, 1:01pm
PersimmonTI @PersimmonTI
$ALDX Interesting— but, FDA risk remains? https://t.co/hVwBQBZeeV
January 11th 2022, 1:01pm
StocksoftheDay_ @StocksoftheDay_
$ALDX Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigationa… https://t.co/aIqjgnnNMQ
January 11th 2022, 1:01pm
FlashAlert_me @FlashAlert_me
$ALDX [15s. delayed]: Issued Press Release on January 11, 08:00:00: Aldeyra Therapeutics Announces Positive Top-Lin… https://t.co/ngYXpI35bj
January 11th 2022, 1:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.